Stepwise genetic changes associated with progression of nontumorigenic HPV-18 immortalized human prostate cancer-derived cell line to a malignant phenotype

Cancer Genetics and Cytogenetics

Volumn 120, Issue 2, 2000, Pages 117-126

  Hukku, Bharati ^a,e   Mally, Michael ^a   Cher, Michael L ^b   Peehl, Donna M ^c   Kung, Hsiang Fu ^d   Rhim, Johng S ^d  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL IMMORTALIZATION; CELL LINE; CHROMOSOME 16; CHROMOSOME 2; CHROMOSOME 4; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; KARYOTYPE; MALIGNANT TRANSFORMATION; METAPHASE; MOUSE; NONHUMAN; NUDE MOUSE; ONCOGENE C MYC; PHENOTYPE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER;

ANEUPLOIDY; ANIMALS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; CHROMOSOME DELETION; CYTOGENETIC ANALYSIS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NUCLEIC ACID HYBRIDIZATION; PAPILLOMAVIRIDAE; PHENOTYPE; PROSTATIC NEOPLASMS; TRANSLOCATION, GENETIC; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

MUS MUSCULUS;

EID: 0034661190     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(00)00216-8     Document Type: Article

References (23)

1. Parker SL, Tong T, Bolded S, Wingo PA (1996): Cancer Statistics. CA Cancer J Clin 46:5-27.
2. Isaacs WB, Bova GS, Morton RA, Bussemakers MJG, Brooks JD, Ewing CM (1995): Molecular genetics and chromosomal alterations in prostate cancer. Cancer Res 75(suppl):2004-2012.
3. Lalani el-N, Laniado ME, Abel PD (1997): Molecular and cellular biology of prostate cancer. Cancer Metastasis Rev 16:29-66.
4. Brothman AR (1997): Cytogenetic studies in prostate cancer: are we making progress? Cancer Genet Cytogenet 95:116-121.
5. Konig JJ, Kamst E, Hagemeijer A, Romijn JC, Horoszewicz J, Schroder FH (1989): Cytogenetic characterization of several androgen responsive and unresponsive sublines of the human prostatic carcinoma cell line LNCaP. Urol Res 17:79-86.
6. Brothman AR, Peehl DM, Patel AM, McNeal JE (1990): Frequency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Res 50:3795-3803.
7. Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JL, Isaacs WB (1990): Allelic loss of chromosome 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87:8751-8755.
8. Bergerheim US, Kunimi K, Collins VP, Ekman P (1991): Deletion mapping of chromosome 8, 10 and 16 in human prostatic carcinoma. Genes Chromosom Cancer 3:215-220.
9. Bova GS, Carter BS, Bussemakers MJG, Emil M, Fujiwara Y, Kyprianou N, Jacobs SC, Robinson JC, Epstein JI, Walsh PC, Issacs WB (1993): Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res 53:3869-3873.
10. Atkin NB, Baker MC (1993): Chromosome 7q deletions. Observations on 13 malignant tumors. Cancer Genet Cytogenet 67:123-125.
11. Arps S, Rodewald A, Schmalenberger B, Carl P, Bressel M, Kastendieck H (1993): Cytogenetic survey of 32 cancers of the prostate. Cancer Genet Cytogenet. 67:93-99.
12. Trybus TM, Tanya M, Burgess AC, Wojno KJ, Glover TW, Macoska JA (1996): Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer. Cancer Res 56:2263-2267.
13. Vocke CD, Possatti RO, Bostwick DG, Florence CD, Jennings SB, Strup SE, Duray PH, Liotta LA, Emmert-Buck MR, Linehan MW (1996): Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. Cancer Res 56:2411-2416.
14. Cher ML, Bova GS, Moore DH, Small EJ, Caroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH (1996): Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization. Cancer Res 56:3091-3102.
15. Smith JR, Freije D, Carpten JD, Gronberg H, Xu J, Isaacs SD, Brownstein MJ, Bova GS, Guo H, Bujnovsky P, Nusskem DR, Damber J-E, Bergh A, Emanuelsson M, Kallioniemi OP, Walker-Daniels, Balley-Wilson JE, Beaty TH, Meyers DA, Walsh PC, Collins FAS, Trent JM, Isaacs WB (1996): Major susceptibility locus for prostate cancer on chromosome 1 suggested by genome wide search. Science 274:1371-1374.
16. Dahiya R, McCarville J, Hu W, Lee C, Chui RM, Kaur G, Deng G (1997): Chromosome 3p24-26 and 3p22-12 loss in human prostatic adenocarcinoma. Int J Cancer 71:20-25.
17. Dahiya R, McCarville J, Lee C, HU W, Kaur G, Carroll P, Deng G (1997): Deletion of chromosome 11p15, p12, q22, q23-24 loci in human prostate cancer. Int J Cancer 72:283-288.
18. Alers JC, Krijtenburg PJ, Rosenberg C, Hop WC, Verkerk AM, Schroder FH, van der Kwast TH, Bosman FT, van Dekken H (1997): Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone. Lab Invest 77:437-448.
19. Jenkins R, Takahashi S, DeLacey K, Bergstralh E, Lieber M (1998): Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in T3N0M0 prostate cancer. Genes Chromosom Cancer 21:131-143.
20. Weijerman PC, Konig JJ, Wong ST, Niesters HGM, Peehl DM (1994): Lipofection-mediated immortalization of human prostatic epithelial cells of normal and malignant origin using human papillomavirus type 18 DNA. Cancer Res 54:5579-5583.
21. Weijerman PC, vanDrunen E, Konig JJ, Teubel W, Romijn JC, Schroder FH, Hagemeijer A (1997): Specific cytogenetic aberrations in two novel human prostatic cell lines immortalized by human papillomavirus type 18 DNA. Cancer Genet Cytogenet 99:108-115.
22. Hukku B, Rhim, JS (1993): Role of chromosome #5 in immortalization and tumorigenesis of human keratinocytes. Cancer Genet Cytogenet 68:22-31.
23. ISCN (1995): An International System for Human Cytogenetic Nomenclature. F Mitelman, ed. S. Karger, Basel.